Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets
Marc Scherlinger(Université de Strasbourg), Patrick Blanco(Centre National de la Recherche Scientifique), Vivien Guillotin(Hôpital Saint-André), Marie‐Elise Truchetet(Centre National de la Recherche Scientifique), Cécile Contin‐Bordes(Centre National de la Recherche Scientifique), Christophe Richez(Centre National de la Recherche Scientifique), P. Duffau(Centre National de la Recherche Scientifique), Estibaliz Lazaro(Centre National de la Recherche Scientifique), Vanja Sisirak(Centre National de la Recherche Scientifique)
Cited by 97
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414